Figure 4

Prognostic analysis of pyroptosis-related lncRNA signature in the training cohort and validation cohort. (a) The distribution of the risk scores in the training cohort. (b) The distribution of the risk scores in the validation cohort. (c) The distributions of overall survival status, overall survival, and risk score in the training cohort. (d) The distributions of overall survival status, overall survival, and risk score in the validation cohort. (e) Kaplan–Meier curves for the overall survival of patients in the high- and low-risk groups in the training cohort. (f) Kaplan–Meier curves for the overall survival of patients in the high- and low-risk groups in the validation cohort. (g) AUC of time-dependent ROC curves verified the prognostic accuracy of the risk score in the training cohort. (h) AUC of time-dependent ROC curves verified the prognostic accuracy of the risk score in the validation cohort.